Differing roles for members of the phospholipase A2 superfamily in experimental autoimmune encephalomyelitis

Brain

Volumn 132, Issue 5, 2009, Pages 1221-1235

  Kalyvas, Athena ^a   Baskakis, Constantinos ^b   Magrioti, Victoria ^b   Constantinou Kokotou, Violetta ^c   Stephens, Daren ^d   Lpez Vales, Rubn ^a   Lu, Jian Qiang ^e   Yong, V Wee ^e   Dennis, Edward A ^d   Kokotos, George ^b   David, Samuel ^a,f  

^a MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

^b UNIVERSITY OF ATHENS   (Greece)

^c AGRICULTURAL UNIVERSITY OF ATHENS   (Greece)

^d UNIVERSITY OF CALIFORNIA   (United States)

^e UNIVERSITY OF CALGARY   (Canada)

^f RESEARCH INSTITUTE OF THE MCGILL UNIVERSITY HEALTH CENTRE   (Canada)

Author keywords

Chemokines; Cytokines; EAE; Fatty acids; Multiple sclerosis; Phospholipase A2

Indexed keywords

FATTY ACID; LYSOPHOSPHOLIPID; PHOSPHOLIPASE A2; PHOSPHOLIPID;

ALLERGIC ENCEPHALOMYELITIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CYTOKINE RELEASE; DEMYELINATION; DISEASE COURSE; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATION; MALE; MOUSE; MULTIPLE SCLEROSIS; NONHUMAN; PRIORITY JOURNAL;

ADULT; AMIDES; ANIMALS; CYTOKINES; DISEASE PROGRESSION; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; ENZYME INHIBITORS; FATTY ACIDS; FEMALE; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; GENE EXPRESSION; HUMANS; IMMUNOHISTOCHEMISTRY; KETONES; MACROPHAGES; MALE; MICE; MICE, INBRED C57BL; MULTIPLE SCLEROSIS; PHOSPHOLIPASES A2; PROTEIN ISOFORMS; RNA, MESSENGER; SPINAL CORD; T-LYMPHOCYTES; YOUNG ADULT;

EID: 66549114353     PISSN: 00068950     EISSN: 14602156     Source Type: Journal    
DOI: 10.1093/brain/awp002     Document Type: Article

References (54)

1. Ajuwon KM, Spurlock ME. Palmitate activates the NF-kappaB transcription factor and induces IL-6 and TNFalpha expression in 3T3-L1 adipocytes. J Nutr 2005; 135: 1841-1846 (Pubitemid 41099739) (Pubitemid 41099739)
2. Ariel A, Serhan CN. Resolvins and protectins in the termination program of acute in?ammation. Trends Immunol 2007; 28: 176-183 (Pubitemid 46467520)
3. Arita M, Clish CB, Serhan CN. The contributions of aspirin and microbial oxygenase to the biosynthesis of anti-in?ammatory resolvins: novel oxygenase products from omega-3 polyunsaturated fatty acids. Biochem Biophys Res Commun 2005; 338: 149-157 (Pubitemid 41540550) (Pubitemid 41540550)
4. Baskakis C, Magrioti V, Cotton N, Stephens D, Constantinou-Kokotou V, Dennis EA, et al. Synthesis of poly?uoro ketones for selective inhibition of human phospholipase A( 2) Enzymes. J Med Chem 2008; 51: 8027-8037
5. Bates D, Cartlidge NE, French JM, Jackson MJ, Nightingale S, Shaw DA, et al. A double-blind controlled trial of long chain n-3 polyunsaturated fatty acids in the treatment of multiple sclerosis. J Neurol Neurosurg Psychiatry 1989; 52: 18-22. (Pubitemid 19043864) (Pubitemid 19043864)
6. Baxter AG. The origin and application of experimental autoimmune encephalomyelitis. Nat Rev Immunol 2007; 7: 904-912 (Pubitemid 350006239) (Pubitemid 350006239)
7. Calder PC. Dietary modi?cation of in?ammation with lipids. Proc Nutr Soc 2002; 61: 345-358
8. Calder PC. N-3 polyunsaturated fatty acids and in?ammation: from molecular biology to the clinic. Lipids 2003; 38: 343-352 (Pubitemid 36724290) (Pubitemid 36724290)
9. Compston A, Coles A. Multiple sclerosis.[ erratum appears in Lancet 2002; 360: 648]. Lancet 2002; 359: 1221-1231 (Pubitemid 34304266) (Pubitemid 34304266)
10. Cunningham TJ, Yao L, Oetinger M, Cort L, Blankenhorn EP, Greenstein JI. Secreted phospholipase A2 activity in experimental auto-immune encephalomyelitis and multiple sclerosis. J Neuroin?ammation 2006; 3: 26. (Pubitemid 44575753)
11. Das UN. Essential fatty acids: biochemistry, physiology and pathology. Biotechnol J 2006; 1: 420-439
12. Dore-Duffy P, Ho SY, Donovan C. Cerebrospinal ?uid eicosanoid levels: endogenous PGD2 and LTC4 synthesis by antigen-presenting cells that migrate to the central nervous system. Neurology 1991; 41: 322-324
13. Folch J, Lees M, Sloane Stanley GH. A simple method for the isolation and puri?cation of total lipides from animal tissues. J Biol Chem 1957; 226: 497-509.
14. Gerstl B, Tavaststjerna MG, Eng LF, Smith JK. Sphingolipids and their precursors in human brain (normal and MS). Z Neurol 1972; 202: 104-120
15. Gilroy DW, Newson J, Sawmynaden P, Willoughby DA, Croxtall JD. A novel role for phospholipase A2 isoforms in the checkpoint control of acute in?ammation. FASEB J 2004; 18: 489-498 (Pubitemid 38326305) (Pubitemid 38326305)
16. Gold R, Linington C, Lassmann H. Understanding pathogenesis and therapy of multiple sclerosis via animal models: 70 years of merits and culprits in experimental autoimmune encephalomyelitis research. Brain 2006; 129: 1953-1971 (Pubitemid 44289062) (Pubitemid 44289062)
17. Huang J, Aki T, Yokochi T, Nakahara T, Honda D, Kawamoto S, et al. Grouping newly isolated docosahexaenoic acid-producing thrausto-chytrids based on their polyunsaturated fatty acid pro?les and comparative analysis of 18S rRNA genes. Mar Biotechnol (NY) 2003; 5: 450-457 (Pubitemid 38043108) (Pubitemid 38043108)
18. Kalyvas A, David S. Cytosolic phospholipase A2 plays a key role in the pathogenesis of multiple sclerosis-like disease. Neuron 2004; 41: 323-335 (Pubitemid 38221038) (Pubitemid 38221038)
19. Karsten S, Schafer G, Schauder P. Cytokine production and DNA synthesis by human peripheral lymphocytes in response to palmitic, stearic, oleic, and linoleic acid. J Cell Physiol 1994; 161: 15-22. (Pubitemid 24315645) (Pubitemid 24315645)
20. Kennedy BP, Payette P, Mudgett J, Vadas P, Pruzanski W, Kwan M, et al. A natural disruption of the secretory group II phospholipase A2 gene in inbred mouse strains. J Biol Chem 1995; 270: 22378-22385
21. Kokotos CG, Baskakis C, Kokotos G. Synthesis of medicinally interesting poly?uoro ketones via per?uoroalkyl lithium reagents. J Org Chem 2008; 73: 8623-8626
22. Kokotos G, Kotsovolou S, Six DA, Constantinou-Kokotou V, Beltzner CC, Dennis EA. Novel 2-oxoamide inhibitors of human group IVA phos- pholipase A( 2). J Med Chem 2002; 45: 2891-2893 (Pubitemid 34721512) (Pubitemid 34721512)
23. Kokotos G, Six DA, Loukas V, Smith T, Constantinou-Kokotou V, Hadjipavlou-Litina D, et al. Inhibition of group IVA cytosolic phospho-lipase A2 by novel 2-oxoamides in vitro, in cells, and in vivo. J Med Chem 2004; 47: 3615-3628 (Pubitemid 38822023) (Pubitemid 38822023)
24. Kollias G, Kontoyiannis D. Role of TNF/TNFR in autoimmunity: speci?c TNF receptor blockade may be advantageous to anti-TNF treatments. Cytokine Growth Factor Rev 2002; 13: 315-321
25. Kontogianni MD, Zampelas A, Tsigos C. Nutrition and in?ammatory load. Ann NY Acad Sci 2006; 1083: 214-238 (Pubitemid 44955475) (Pubitemid 44955475)
26. Kudo I, Murakami M. Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat 2002; 68-69: 3-58.
27. Lopez-Vales R, Navarro X, Shimizu T, Baskakis C, Kokotos G, Constantinou-Kokotou V, et al. Intracellular phospholipase A2 group IVA and group VIA play important roles in Wallerian degeneration and axon regeneration after peripheral nerve injury. Brain 2008; 131: 2620-2631
28. Marusic S, Leach MW, Pelker JW, Azoitei ML, Uozumi N, Cui J, et al. Cytosolic phospholipase A2 alpha-de?cient mice are resistant to experimental autoimmune encephalomyelitis. J Exp Med 2005; 202: 841-851 (Pubitemid 41345972) (Pubitemid 41345972)
29. Nordvik I, Myhr KM, Nyland H, Bjerve KS. Effect of dietary advice and n-3 supplementation in newly diagnosed MS patients. Acta Neurol Scand 2000; 102: 143-149 (Pubitemid 30645133) (Pubitemid 30645133)
30. Noseworthy JH, Lucchinetti C, Rodriguez M, Weinshenker BG. Multiple sclerosis. [see comment]. N Engl J Med 2000; 343: 938-952
31. Ousman SS, David S. Lysophosphatidylcholine induces rapid recruitment and activation of macrophages in the adult mouse spinal cord. Glia 2000; 30: 92-104. (Pubitemid 30172156) (Pubitemid 30172156)
32. Ousman SS, David S. MIP-1alpha, MCP-1, GM-CSF, and TNF-alpha control the immune cell response that mediates rapid phagocytosis of myelin from the adult mouse spinal cord. J Neurosci 2001; 21: 4649-4656 (Pubitemid 32565623) (Pubitemid 32565623)
33. Pinto F, Brenner T, Dan P, Krimsky M, Yedgar S. Extracellular phospho-lipase A2 inhibitors suppress central nervous system in?ammation. Glia 2003; 44: 275-282 (Pubitemid 37484478) (Pubitemid 37484478)
34. Poltorak AN, Bazzoni F, Smirnova, II, Alejos E, Thompson P, Luheshi G, et al. MIP-1 gamma: molecular cloning, expression, and biological activities of a novel CC chemokine that is constitutively secreted in vivo. J In?amm 1995; 45: 207-219
35. Rocha PN, Plumb TJ, Coffman TM. Eicosanoids: lipid mediators of in?ammation in transplantation. Springer Semin Immunopathol 2003; 25: 215-227 (Pubitemid 37130015)
36. Rothenberg ME, Hogan SP. The eosinophil. Annu Rev Immunol 2006; 24: 147-174
37. Samoilova EB, Horton JL, Chen Y. Acceleration of experimental autoim-mune encephalomyelitis in interleukin-10-de?cient mice: roles of inter-leukin-10 in disease progression and recovery. Cell Immunol 1998; 188: 118-124 (Pubitemid 28493564) (Pubitemid 28493564)
38. Sargent JR, Coupland K, Wilson R. Nervonic acid and demyelinating disease. Med Hypotheses 1994; 42: 237-242 (Pubitemid 24146396) (Pubitemid 24146396)
39. Schaloske RH, Dennis EA. The phospholipase A2 superfamily and its group numbering system. Biochim Biophys Acta 2006; 1761: 1246-1259 (Pubitemid 44755364) (Pubitemid 44755364)
40. Serhan CN. Resolution phase of in?ammation: novel endogenous anti-in?ammatory and proresolving lipid mediators and pathways. Annu Rev Immunol 2007; 25: 101-137 (Pubitemid 46697904) (Pubitemid 46697904)
41. Simmons RD, Hugh AR, Willenborg DO, Cowden WB. Suppression of active but not passive autoimmune encephalomyelitis by dual cyclo-oxygenase and 5-lipoxygenase inhibition. Acta Neurol Scand 1992; 85: 197-199
42. Simopoulos AP. Evolutionary aspects of diet, the omega-6/omega-3 ratio and genetic variation: nutritional implications for chronic diseases. Biomed Pharmacother 2006; 60: 502-507
43. Six DA, Barbayianni E, Loukas V, Constantinou-Kokotou V, Hadjipavlou-Litina D, Stephens D, et al. Structure-activity relationship of 2-oxoa-mide inhibition of group IVA cytosolic phospholipase A2 and group V secreted phospholipase A2. J Med Chem 2007; 50: 4222-4235 (Pubitemid 47301753) (Pubitemid 47301753)
44. Steinman L, Martin R, Bernard C, Conlon P, Oksenberg JR. Multiple sclerosis: deeper understanding of its pathogenesis reveals new targets for therapy. Ann Rev Neurosci 2002; 25: 491-505. (Pubitemid 34748026) (Pubitemid 34748026)
45. Steinman L, Zamvil SS. How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis. Ann Neurol 2006; 60: 12-21.
46. Stentz FB, Kitabchi AE. Palmitic acid-induced activation of human T-lymphocytes and aortic endothelial cells with production of insulin receptors, reactive oxygen species, cytokines, and lipid peroxidation. Biochem Biophys Res Commun 2006; 346: 721-726 (Pubitemid 43913678) (Pubitemid 43913678)
47. Stephens D, Barbayianni E, Constantinou-Kokotou V, Peristeraki A, Six DA, Cooper J, et al. Differential inhibition of group IVA and group VIA phospholipases A2 by 2-oxoamides. J Med Chem 2006; 49: 2821-2828
48. Trapp BD, Peterson J, Ransohoff RM, Rudick R, Mork S, Bo L. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 1998; 338: 278-285 (Pubitemid 28065253) (Pubitemid 28065253)
49. van der Valk P, De Groot CJ. Staging of multiple sclerosis (MS) lesions: pathology of the time frame of MS. Neuropathol Appl Neurobiol 2000; 26: 2-10. (Pubitemid 30145301) (Pubitemid 30145301)
50. van Oosten BW, Barkhof F, Truyen L, Boringa JB, Bertelsmann FW, von Blomberg BM, et al. Increased MRI activity and immune activation in two multiple sclerosis patients treated with the monoclonal anti-tumor necrosis factor antibody cA2. Neurology 1996; 47: 1531-1534 (Pubitemid 26422549) (Pubitemid 26422549)
51. Weber F, Hempel K. Protection against experimental allergic encephalo-myelitis with complete Freund's adjuvant is unaffected by prostaglan-din synthesis inhibition. Int Arch Allergy Appl Immunol 1989; 89: 242-245 (Pubitemid 19209645) (Pubitemid 19209645)
52. Weinstock-Guttman B, Baier M, Park Y, Feichter J, Lee-Kwen P, Gallagher E, et al. Low fat dietary intervention with omega-3 fatty acid supplementation in multiple sclerosis patients. Prostaglandins Leukot Essent Fatty Acids 2005; 73: 397-404. (Pubitemid 41375637) (Pubitemid 41375637)
53. Whitney LW, Ludwin SK, McFarland HF, Biddison WE. Microarray analysis of gene expression in multiple sclerosis and EAE identi?es 5-lipox-ygenase as a component of in?ammatory lesions. J Neuroimmunol 2001; 121: 40-48 (Pubitemid 34008449) (Pubitemid 34008449)
54. Yaksh TL, Kokotos G, Svensson CI, Stephens D, Kokotos CG, Fitzsimmons B, et al. Systemic and intrathecal effects of a novel series of phospholipase A2 inhibitors on hyperalgesia and spinal pros-taglandin E2 release. J Pharmacol Exp Ther 2006; 316: 466-475 (Pubitemid 41832627) (Pubitemid 41832627)